Impact of Low-dose Tamoxifen on BPU
Completed · Not applicable
Conditions studied: High Background Uptake on MBI
In brief
The study will examine whether changes in background parenchymal uptake (BPU) on molecular breast imaging (MBI) can be induced by short-term use of low-dose tamoxifen. Women who have previously had high BPU on MBI will be recruited. Participants will take low-dose tamoxifen for a 30-day period, with post-tamoxifen MBI in order to investigate the impact of tamoxifen on BPU.
Key facts
- Study ID
- NCT02979301
- Run by
- Mayo Clinic
- People needed
- 22
- Starts
- 2017-03-01
- Expected to finish
- 2018-11-01
- Last updated by the study team
- 2019-07-16
Who can join
Age: 40 and older. Sex: female. Healthy volunteers: accepted.
Where it is running
- Mayo Clinic — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.